Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy

NCT02936843 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes
Peripheral Neuropathy

Interventions

DRUG: Salsalate
DRUG: PLACEBO

Sponsor

University of Michigan